Covalon Technologies Stock Fundamentals
| CVALF Stock | USD 2.65 0.03 1.15% |
Covalon Technologies fundamentals help investors to digest information that contributes to Covalon Technologies' financial success or failures. It also enables traders to predict the movement of Covalon OTC Stock. The fundamental analysis module provides a way to measure Covalon Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Covalon Technologies otc stock.
Covalon |
Covalon Technologies OTC Stock Operating Margin Analysis
Covalon Technologies' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Covalon Technologies Operating Margin | (0.50) % |
Most of Covalon Technologies' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Covalon Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Covalon Technologies has an Operating Margin of -0.5038%. This is 98.56% lower than that of the Biotechnology sector and 99.55% lower than that of the Health Care industry. The operating margin for all United States stocks is 90.86% lower than that of the firm.
Covalon Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Covalon Technologies's current stock value. Our valuation model uses many indicators to compare Covalon Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Covalon Technologies competition to find correlations between indicators driving Covalon Technologies's intrinsic value. More Info.Covalon Technologies is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Covalon Technologies' earnings, one of the primary drivers of an investment's value.Covalon Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Covalon Technologies' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Covalon Technologies could also be used in its relative valuation, which is a method of valuing Covalon Technologies by comparing valuation metrics of similar companies.Covalon Technologies is currently under evaluation in operating margin category among its peers.
Covalon Fundamentals
| Return On Equity | -0.32 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | (0.53) % | |||
| Operating Margin | (0.50) % | |||
| Current Valuation | 35.37 M | |||
| Shares Outstanding | 25.07 M | |||
| Shares Owned By Insiders | 56.60 % | |||
| Price To Earning | 37.95 X | |||
| Price To Book | 2.12 X | |||
| Price To Sales | 2.30 X | |||
| Revenue | 18.15 M | |||
| Gross Profit | 7.49 M | |||
| EBITDA | (8.11 M) | |||
| Net Income | (9.66 M) | |||
| Cash And Equivalents | 14.04 M | |||
| Cash Per Share | 0.55 X | |||
| Total Debt | 2.25 M | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 10.04 X | |||
| Book Value Per Share | 0.96 X | |||
| Cash Flow From Operations | (7.99 M) | |||
| Earnings Per Share | 0.05 X | |||
| Number Of Employees | 24 | |||
| Beta | 1.19 | |||
| Market Capitalization | 41.36 M | |||
| Total Asset | 30.38 M | |||
| Z Score | 10.8 | |||
| Net Asset | 30.38 M |
About Covalon Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Covalon Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Covalon Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Covalon Technologies based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. It serves hospitals, wound care centers, burn centers, extendedalternate care and acute care facilities, home health care agencies, and physicians offices. Covalon Tech operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Covalon OTC Stock
Covalon Technologies financial ratios help investors to determine whether Covalon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Covalon with respect to the benefits of owning Covalon Technologies security.